Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Operating Expenses: 2011-2025

Historic Operating Expenses for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $150.7 million.

  • Enanta Pharmaceuticals' Operating Expenses fell 24.63% to $33.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.7 million, marking a year-over-year decrease of 20.42%. This contributed to the annual value of $150.7 million for FY2025, which is 20.42% down from last year.
  • As of FY2025, Enanta Pharmaceuticals' Operating Expenses stood at $150.7 million, which was down 20.42% from $189.3 million recorded in FY2024.
  • Enanta Pharmaceuticals' 5-year Operating Expenses high stood at $216.4 million for FY2023, and its period low was $150.7 million during FY2025.
  • Over the past 3 years, Enanta Pharmaceuticals' median Operating Expenses value was $189.3 million (recorded in 2024), while the average stood at $185.5 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Operating Expenses increased by 25.92% in 2021 and then fell by 20.42% in 2025.
  • Enanta Pharmaceuticals' Operating Expenses (Yearly) stood at $206.6 million in 2021, then grew by 1.62% to $210.0 million in 2022, then climbed by 3.05% to $216.4 million in 2023, then fell by 12.52% to $189.3 million in 2024, then fell by 20.42% to $150.7 million in 2025.